Stock PEN PENUMBRA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Penumbra, Inc.

Equities

PEN

US70975L1070

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX
Other stock markets
 11:51:59 2024-04-26 am EDT 		5-day change 1st Jan Change
204.4 USD -0.51% Intraday chart for Penumbra, Inc. +0.55% -18.96%
Apr. 23 Penumbra, Inc. Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots CI
Apr. 17 DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment MT

Business Summary

Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.

Number of employees: 4,200

Sales per Business

USD in Million2022Weight2023Weight Delta
Thrombectomy
64.0 %
- - 677 64.0 % -
Embolization and Access
36.0 %
- - 381 36.0 % -

Sales per region

USD in Million2022Weight2023Weight Delta
United States
71.5 %
592 69.8 % 757 71.5 % +27.96%
International
28.5 %
255 30.2 % 301 28.5 % +17.99%

Managers

Managers TitleAgeSince
Arani Bose FOU
 Founder 62 04-06-20
Adam Elsesser CEO
 Chief Executive Officer 62 04-06-20
Maggie Yuen DFI
 Director of Finance/CFO 52 19-12-01
Ben Sorci COO
 Chief Operating Officer - 04-12-31
Corey Teigen CTO
 Chief Tech/Sci/R&D Officer - 20-07-13
Pankaj Tiwari CTO
 Chief Tech/Sci/R&D Officer - 15-12-31
James Benenati CTO
 Chief Tech/Sci/R&D Officer - 20-08-31
Lambert Shiu AUD
 Comptroller/Controller/Auditor 44 14-12-31
Johanna Roberts LAW
 General Counsel 52 13-12-31
Michaella Corso PRN
 Corporate Officer/Principal - 15-12-31

Members of the board

Members of the board TitleAgeSince
Thomas Wilder BRD
 Director/Board Member 60 17-01-12
Harpreet Grewal BRD
 Director/Board Member 57 15-03-31
Adam Elsesser CEO
 Chief Executive Officer 62 04-06-20
Arani Bose FOU
 Founder 62 04-06-20
Don Kassing BRD
 Director/Board Member 82 08-01-31
Surbhi Sarna BRD
 Director/Board Member 38 19-06-30
Bridget O'Rourke BRD
 Director/Board Member 56 17-04-20
Janet Leeds BRD
 Director/Board Member 62 19-01-16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 38,757,817 37,226,197 ( 96.05 %) 0 96.05 %

Shareholders

NameEquities%Valuation
Fidelity Management & Research Co. LLC
14.96 %
5,788,971 14.96 % 1 292 M $
BlackRock Advisors LLC
9.760 %
3,777,284 9.760 % 843 M $
Vanguard Fiduciary Trust Co.
9.452 %
3,658,103 9.452 % 816 M $
T. Rowe Price International Ltd.
8.021 %
3,104,590 8.021 % 693 M $
Capital Research & Management Co. (Global Investors)
6.919 %
2,677,789 6.919 % 598 M $
STATE STREET CORPORATION
2.845 %
1,101,107 2.845 % 246 M $
Adam Elsesser
2.487 %
962,582 2.487 % 215 M $
ClearBridge Investments LLC
2.069 %
800,827 2.069 % 179 M $
William Blair Investment Management LLC
1.920 %
743,259 1.920 % 166 M $
RTW Investments LP
1.712 %
662,664 1.712 % 148 M $

Company contact information

Penumbra, Inc.

One Penumbra Place

94502, Alameda

+510 748 3200

http://www.penumbrainc.com
address Penumbra, Inc.(PEN)

Group companies

NameCategory and Sector
Crossmed SpA
Logo Crossmed SpA

Crossmed SpA

Medical SpecialtiesHealth Technology

Crossmed SpA distributes medical supplies and equipment in Italy, San Marino, the Vatican, and Switzerland. The company was founded in 2007 and is headquartered in Grugliasco, Italy.

Medical Specialties

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Medical Equipment

Sales per Business

Sales per region

Ratings for Penumbra, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
205.5 USD
Average target price
280.1 USD
Spread / Average Target
+36.29%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

1st Jan change Capi.
PENUMBRA, INC. Stock Penumbra, Inc.
-18.30% 7.96B
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+72.64% 12.34B
MASIMO CORPORATION Stock Masimo Corporation
+15.38% 7.16B
GETINGE AB Stock Getinge AB
+5.13% 5.72B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+6.51% 5.03B
APT MEDICAL INC. Stock APT Medical Inc.
+21.99% 4.35B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-21.67% 3.99B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-41.36% 2.21B
SKAN GROUP AG Stock SKAN Group AG
+0.37% 2.01B
SHENZHEN YHLO BIOTECH CO., LTD. Stock Shenzhen YHLO Biotech Co., Ltd.
+2.93% 1.85B
Medical Equipment
  1. Stock Market
  2. Equities
  3. PEN Stock
  4. Company Penumbra, Inc.